Fundación Mundo Sano Report issue

Foundation

Organization Overview

First Clinical Trial
2010
NCT01308268
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Fundacion Mundo Sano

Active Ingredients

Drugs in Other Trials (2)

albendazole (Albenza) (3 trials)

ivermectin (stromectol) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 2